US Stock MarketDetailed Quotes

Rapport Therapeutics (RAPP)

Watchlist
  • 30.200
  • -0.730-2.36%
Close Dec 26 15:59 ET
  • 30.200
  • 0.0000.00%
Post 16:10 ET
1.44BMarket Cap-14.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rapport Therapeutics (RAPP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
38.57%29.99M
41.81%29.5M
58.58%27.11M
129.57%83.06M
58.99%23.52M
126.27%21.64M
213.73%20.8M
229.30%17.09M
36.18M
14.79M
Selling and administrative expenses
26.41%7.71M
33.36%6.82M
64.18%7.54M
170.42%22.12M
111.09%6.32M
207.31%6.1M
167.73%5.11M
255.26%4.59M
--8.18M
--3M
-General and administrative expense
26.41%7.71M
33.36%6.82M
64.18%7.54M
170.42%22.12M
111.09%6.32M
207.31%6.1M
167.73%5.11M
255.26%4.59M
--8.18M
--3M
Research and development costs
43.34%22.28M
44.56%22.68M
56.53%19.57M
117.63%60.94M
45.77%17.2M
105.05%15.54M
232.32%15.69M
220.70%12.5M
--28M
--11.8M
Operating profit
-38.57%-29.99M
-41.81%-29.5M
-58.58%-27.11M
-129.57%-83.06M
-58.99%-23.52M
-126.27%-21.64M
-213.73%-20.8M
-229.30%-17.09M
-36.18M
-14.79M
Net non-operating interest income expense
-25.40%3.06M
3.17%2.76M
67.77%3.05M
380.33%12.14M
157.53%3.54M
379.32%4.1M
1,112.22%2.68M
2,320.00%1.82M
2.53M
1.38M
Non-operating interest income
-25.40%3.06M
3.17%2.76M
67.77%3.05M
380.33%12.14M
157.53%3.54M
379.32%4.1M
1,112.22%2.68M
2,320.00%1.82M
--2.53M
--1.38M
Other net income (expense)
-557.47%-7.39M
0
-617.48%-7.39M
-1.12M
-94K
Other non- operating income (expenses)
----
----
----
-557.47%-7.39M
--0
----
----
-617.48%-7.39M
---1.12M
---94K
Income before tax
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-125.18%-78.31M
-47.86%-19.98M
-101.39%-17.54M
-182.74%-18.12M
-268.84%-22.67M
-34.78M
-13.51M
Income tax
0
0
0
0
0
10K
6K
Net income
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-125.11%-78.31M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
-34.79M
-13.52M
Net income continuous Operations
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-125.11%-78.31M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
---34.79M
---13.52M
Minority interest income
Net income attributable to the parent company
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-125.11%-78.31M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
-34.79M
-13.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-125.11%-78.31M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
-34.79M
-13.52M
Basic earnings per share
-42.00%-0.71
55.88%-0.75
-6.12%-0.68
83.64%-3.78
-49.16%-0.57
-38.90%-0.5
-541.54%-1.7
-152.21%-0.6408
-23.1
-0.3821
Diluted earnings per share
-42.00%-0.71
55.88%-0.75
-6.12%-0.68
83.64%-3.78
-49.16%-0.57
-38.90%-0.5
-541.54%-1.7
-152.21%-0.6408
-23.1
-0.3821
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 38.57%29.99M41.81%29.5M58.58%27.11M129.57%83.06M58.99%23.52M126.27%21.64M213.73%20.8M229.30%17.09M36.18M14.79M
Selling and administrative expenses 26.41%7.71M33.36%6.82M64.18%7.54M170.42%22.12M111.09%6.32M207.31%6.1M167.73%5.11M255.26%4.59M--8.18M--3M
-General and administrative expense 26.41%7.71M33.36%6.82M64.18%7.54M170.42%22.12M111.09%6.32M207.31%6.1M167.73%5.11M255.26%4.59M--8.18M--3M
Research and development costs 43.34%22.28M44.56%22.68M56.53%19.57M117.63%60.94M45.77%17.2M105.05%15.54M232.32%15.69M220.70%12.5M--28M--11.8M
Operating profit -38.57%-29.99M-41.81%-29.5M-58.58%-27.11M-129.57%-83.06M-58.99%-23.52M-126.27%-21.64M-213.73%-20.8M-229.30%-17.09M-36.18M-14.79M
Net non-operating interest income expense -25.40%3.06M3.17%2.76M67.77%3.05M380.33%12.14M157.53%3.54M379.32%4.1M1,112.22%2.68M2,320.00%1.82M2.53M1.38M
Non-operating interest income -25.40%3.06M3.17%2.76M67.77%3.05M380.33%12.14M157.53%3.54M379.32%4.1M1,112.22%2.68M2,320.00%1.82M--2.53M--1.38M
Other net income (expense) -557.47%-7.39M0-617.48%-7.39M-1.12M-94K
Other non- operating income (expenses) -------------557.47%-7.39M--0---------617.48%-7.39M---1.12M---94K
Income before tax -53.53%-26.93M-47.52%-26.73M-6.15%-24.06M-125.18%-78.31M-47.86%-19.98M-101.39%-17.54M-182.74%-18.12M-268.84%-22.67M-34.78M-13.51M
Income tax 0000010K6K
Net income -53.53%-26.93M-47.52%-26.73M-6.15%-24.06M-125.11%-78.31M-47.79%-19.98M-101.37%-17.54M-182.65%-18.12M-268.78%-22.67M-34.79M-13.52M
Net income continuous Operations -53.53%-26.93M-47.52%-26.73M-6.15%-24.06M-125.11%-78.31M-47.79%-19.98M-101.37%-17.54M-182.65%-18.12M-268.78%-22.67M---34.79M---13.52M
Minority interest income
Net income attributable to the parent company -53.53%-26.93M-47.52%-26.73M-6.15%-24.06M-125.11%-78.31M-47.79%-19.98M-101.37%-17.54M-182.65%-18.12M-268.78%-22.67M-34.79M-13.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -53.53%-26.93M-47.52%-26.73M-6.15%-24.06M-125.11%-78.31M-47.79%-19.98M-101.37%-17.54M-182.65%-18.12M-268.78%-22.67M-34.79M-13.52M
Basic earnings per share -42.00%-0.7155.88%-0.75-6.12%-0.6883.64%-3.78-49.16%-0.57-38.90%-0.5-541.54%-1.7-152.21%-0.6408-23.1-0.3821
Diluted earnings per share -42.00%-0.7155.88%-0.75-6.12%-0.6883.64%-3.78-49.16%-0.57-38.90%-0.5-541.54%-1.7-152.21%-0.6408-23.1-0.3821
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +1.02%
Sample Name
Sample Code
 +0.89%
Sample Name
Sample Code
 +0.86%
4
Palo Alto Networks
PANW
+0.66%
5
Broadcom
AVGO
+0.55%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.72%
Sample Name
Sample Code
 +8.72%
Sample Name
Sample Code
 +7.79%
4
Zai Lab
ZLAB
+6.69%
5
Taiwan Semiconductor
TSM
+6.38%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -